Safety device for prefilled syringes approved by US FDA

Published: 26-Aug-2011
Packaging Regulatory

Safe’n’Sound protects against needle stick injuries

Plastic packaging specialist Rexam Healthcare has received 510(k) approval from the US Food and Drug Administration (FDA) for its passive safety device for staked prefilled syringes.

The Safe’n’Sound device provides effective protection against the risks of being pricked by a soiled needle, thanks to a protective sheath that activates automatically once the medicine has been administered, the company says.

Rexam says the approval for the device is the ‘crowning achievement of significant investment and efforts in terms of design by the Rexam teams’.

The Safe’n’Sound device can now be marketed in the US.

With more than 3,000 staff and 15 factories across three continents, Rexam Healthcare is a global leader in healthcare rigid plastic packaging and devices.

  • Companies:
  • Nemera
See more

You may also like

Manufacturing

Nemera extends manufacturing capabilities in North America

Read more
With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago

Trending Articles

  1. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  2. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  3. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  4. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
  5. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Nemera extends manufacturing capabilities in North America

With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Regulatory

Nemera updates branding and website

“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner”
Packaging

Nemera's Advancia Snap-on nasal spray pump launches in South Korea

JW Pharmaceutical has released its decongestant range for adults and kids
Manufacturing

Nemera receives drug manufacturing authorisation for Neuenburg plant

Nemera received pharmaceutical drug manufacturing authorisation from the German Government Drug Administration in accordance with German Drug and Medicinal Product law, at its Neuenburg manufacturing facility in Germany
Packaging

Nemera wins Editor’s choice at Interphex

Nemera has won the “Editor’s choice” category at the annual Interphex Awards, for its two step autoinjector, Safelia
Packaging

Nemera Safelia autoinjector wins Pharmapack award

A team of industry experts judge Nemera’s autoinjector as Best Exhibitor Innovation for Patient Centricity and Customisation
Packaging

Rexam proposes sale of remaining healthcare business to Berry Plastics

Sale of two other divisions announced at the beginning of February proceeding on schedule
Subscribe now